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Although Weil's  disease  has  been  recognized  since  antiquity  and
its  mortality  has  been  high,  treatment  up  to  the  present  time  has
been  purely  symptomatic,  as  the  causative  agent  was  not  known.
But with  the discovery  of  the cause,  we have  now entered  upon the
study of the specific therapy.  In the course  of their discovery  of the
causative  agent,  Inada and  Ido' found  in the  blood serum  obtained
from recovered cases  of the disease an immune body which acted as a
solvent  and destroyed  the spirochetes  contained in the blood and the
liver  of  the  guinea  pigs  under  experimentation;  on the  basis  of  this
work  they  advanced  the  hypothesis  that  serum  therapy  should  be
effective  in  Weil's  disease.
In his  experimental  investigation  Ido  obtained  remarkable  results
with  convalescent  serum  and  active  serum  from  immunized  goats.
He  demonstrated  that  the  immune  serum,  if  injected  prior  to  the
appearance  of icterus, is capable of inhibiting the disease  in all cases.
This work forms  the basis  of  the serum  therapy  of Weil's  disease in
man.  On  the  other  hand,  experiments  undertaken  with  salvarsan,
as  already  indicated  elsewhere,2  were  not  followed  by  comparable
results.  For these  reasons  we have been led to employ antiserum  in
the  treatment  of  Weil's  disease  since  August,  1915;  and  we  were
in a position to report the results of our work as early as October,  1915.
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Up to the present time serum therapy has not been widely employed
in  the  spirochetal  diseases.  Since  the  serum  therapy  of  readily  re-
lapsing spirilloses  leads to the formation  of a serum-fast  strain, it has
been  claimed  that salvarsan  would  be  more  suitable  for treatment
in  these  cases.  But  in  Weil's  disease  a  serum-fast  strain  does  not
occur.  Spirochetolytic  and spirochetocidal  immune bodies,  however,
develop  in  the blood,  and  the  immunity lasts  for  several  years,  the
antibodies  having  in one  case  been  unmistakably  detected  8  years
after recovery.  Relapse  apparently  does not occur  in Weil's disease.
We  have  never  found  a  case  of  it,  although  Fiedler  recognizes  it.
Inada  and Ido have given  the term "after fever"  to the fever which
occurs  on the  14th or 15th  day  from  the onset of  the disease,  some-
times  on the  13th to the 16th day, less frequently  on the 12th to the
17th,  and which continues  for several  days, often from  7 to 10.  But
this  cannot  be  considered  a  relapse  in  the  real  sense  of  the  word,
because at this stage of  the disease  we  do  not find the spirochetes  in
the blood, or in any organs but the kidneys.
We  employed  first  serum  from  recovered  cases  and  later  serum
obtained  from  actively  immunized  horses.  As human  convalescent
serum  is not procurable  in large  quantities,  a  horse  was  immunized
with  Spirocheeta icterohmorrhagie.  The  goat  also  can  be  readily
immunized,  but  is  too  small  an  animal  to  yield  large  amounts  of
serum.  At the present  time we possess two actively immune  horses,
which  are  able  to  take  an  injection  of  800  cc.  of  pure  culture,  con-
taining  30  spirochetes  per  field,  under  dark-field  illumination  (fr
oil immersion,  No.  3  ocular,  Leitz).
The  serum  which  we  now  have  is  far  more  potent  than  that  ob-
tained  at  the  beginning.  0.01  cc.  of  the  present  serum  injected
simultaneously with a pure culture into  the peritoneal cavity protects
a  guinea pig  weighing  200  gm.  against  infection  from  1 cc.  of  pure
culture  (10  spirochetes  per  field).  In  the treatment  of the patients
considered  here,  the  serum  was  of  weaker  concentration,  as  much
as 0.5  cc. of the serum  being required  to protect a guinea pig against
infection  from  a  similar  dose  of  culture.  Inasmuch  as  our  most
potent serum  was  obtained  only toward  the end  of  1915,  the oppor-
tunity to test its action did not arise, as we have had no cases of Weil's
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To  the serum  obtained from horses,  0.5 per  cent  carbolic  acid was
added and it was kept in the ice  box for 1 month.  It  was then tested
for tetanus  toxin  and  carbolic  acid  content,  and  also by cultures,  to
establish sterility.  We  employed serum taken on July 12, August 28,
September  19, and  October  11  from  Horse  1.  35  patients  in all  re-
ceived  the treatment;  23 in the clinic  and 12  cases occurring in a coal
mine.  Of  these  patients,  6  were  treated  with  human convalescent
serum,  2  with  both  horse  and  human  serum, and  the remaining  27
patients  with  horse  serum  alone.  As  the  titer  of  the  horse  serum
about equalled  that of the human serum, the cases treated will be dis-
cussed jointly.
Dose of Serum Injected.--The initial daily dose for 3 days was 10 cc.,
but our experience  derived  from a  number  of  cases  shows that  this
dosage is  ineffectual.  For that reason we employed gradually larger
doses,  until finally we injected 60  cc. in 24 hours.  This quantity  of
serum  was  given  in  three  amounts,  with  intervals  of  from  5  to  6
hours.  Of late, we have made intravenous injections with good results.
It  was  feared  in the  beginning  that  the  toxin  liberated  by  lysis  of
the  spirochetes  would  prove  harmful  to the  organism,  but  this  fear
proved  to be unfounded.
The  day  on  which  serum  treatment  was  instituted  is  shown  in
Table I.
TABLE  I.
Day of  illness.  No.  of cases.
2  4
3  4
4  5
5  6
6  8
7  3
8  5
In 24 of the cases icterus was present at the beginning of the serum
treatment;  11  cases showed no icterus when the treatment was begun;
and  in 5 there was  no icterus  during  the  course  of  the disease.  As
the serum, according  to our experience,  is mainly spirochetolytic and
spirochetocidal  in  action,  and  its  antitoxic  effect  has  not  yet  been
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demonstrated,  it  is  recommended  that  it  should  be  employed  as
early  as  possible  after  the  onset  of  the disease,-if  possible,  before
the  5th  day  of  illness,  when  there  are  probably  many  spirochetes
present  in the  organs.  The distribution  from the point  of  intensity
of the disease was  as  follows:  17  severe  cases,  17 moderately  severe,
and  1 mild  case.
The criteria employed to determine the result of the serum therapy
were:
1. The rate  of mortality.
2. The influence of the serum upon the spirochetes  in the circulating blood.
3. The effect of the serum on an earlier development  of antibodies.
4. The  number  of  spirochetes  found  in  the  organs  after  death,  when  serum
treatment  had been  employed.
5. The  influence upon  the symptoms and  the progress of  the disease.
Of these criteria, special  emphasis has been placed upon Nos. 2 and
3,  inasmuch as  they afford  definite objective  phenomena  for judging
the effect  of  the  serum treatment,  and are  valid  even if  the number
of  patients  is  small,  while  for  the  other  criteria  a large  number of
observations  is  required.  The  difficulty  of  determining  the  effect
upon  the symptoms  and the course of  the disease in individual  cases
increases  with an early use  of the serum,  as in that case it is not easy
to  decide  whether  the  slight  illness  is  attributable  to  the serum,  or
whether the  disease as such  was of a  mild character.  The prognosis
in most  cases  is determined  at the height of  illness, or  on the 7th  or
8th day from the onset.
Mortality in Weil's Disease.
Of the 35 patients who received  the serum  treatment,  7 died.  Of
this  number,  2 showed complications,  1 developed  suppurative  men-
ingitis  on the  27th  day  of  the  disease,  and  another  patient  who
had  a  suppurative  process  died  after  2 months.  This  leaves  only
5 cases in which  the  cause  of  death  is attributable  to Weil's  disease
itself rather  than to a complication.  Of these, one patient, who was
admitted  in  a  moribund  condition  and  died  on  the  following  day,
has  not  been  included.  Omitting  these  cases,  the  mortality  was
found  to be  11.4 per cent.  If we exclude  also the 12  patients in the
coal mine and include only the 23 cases  treated at the clinic, the mor-
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According  to Oguro,  the mortality  of  Weil's disease in Japan is  40
per cent, according to Nishi, 48 per cent; and according to Inada, 30.6
per cent.  As  we are not in possession  of  definite data regarding  the
death  rate  among  the  patients  in  the  coal  mine,  we  haveexcluded
these  cases and have compared  only the mortality  of  patients in  our
clinic,  treated  with  serum  or  otherwise,  with  the  general  statistics.
The  mortality in our clinic  up to last  year was  30.6 per  cent.  With
the beginning of the serum therapy, it will be seen that the mortality
is  reduced  almost  to  two-thirds.  It must, however,  be  stated that
we have, during the past year and since the discovery  of the causative
agent, accepted a relatively large number of patients, and among these
there were  probably  a number who  had  the disease  in a  mild  form.
In view of the reduction  in  the mortality rate,  at the moment,  we
shall limit our claim  to the statement that the administration  of  the
serum  has a marked  effect  in Weil's disease,  and  we  shall  await  the
results obtained  from a large  number of  cases  before making  a more
positive assertion.
The Behavior of Spirocheta icterohcemorrhagie  in the Circulating  Blood
after Serum Injection.
We  desire  to present  in  brief  form the  result  of  infection  experi-
ments carried  out with the blood  of patients  who  received  no serum
treatment.  Table  II  shows  the  result  of  this  investigation  which
comprises 68 cases, arranged  according to the day of illness.
TABLE  II.
Infection Experiments with Blood from Weil's Disease.
Day  of illness.  No. of cases.  Results.  Per cent of Day  of illness.  No.  of cases. positive  results.
Negative.  Positive.
Up  to 4  26  26  100.0
5  12  1  11  91.6
6  14  2  12  85.7
7  8  4  4  50.0
8  4  4  0  0
9  1  1  100.0
12  1  1  0
18  1  1  0
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It  will be  seen  that in all  cases up  to the  4th  day  of  illness,  the
result  was  positive;  of  the  experiments  undertaken  on the  5th  day
91.6 per cent were positive;  on the 6th day, 85.7 per cent; on the 7th,
50 per  cent.  From  the 8th day on,  of blood  taken  from  8 patients,
only one, that taken on the 9th day, proved to be positive.
In  order  to  determine  whether  the  dose  of  serum  employed  is
capable  of  killing  and  dissolving  the  spirochetes  in  the  circulating
blood  of the patient,  blood was  taken, before  the injection  of  serum,
from  the arm  vein  of  the patient and injected  intraperitoneally  into
guinea pigs; and, similarly, another sample of  blood  was drawn  after
the  injection  of  the  serum.  If,  then,  the  guinea  pig  receiving  the
blood  drawn before the injection  of serum became typically  ill, while
that receiving the blood drawn after serum had been injected into the
patient remained well, the last drawing of blood having been made on
the 4th day  of the disease,  we may  conclude that, in the latter  case,
the  spirochetes  in  the  circulating  blood  had  been destroyed  by the
serum.  When the blood is taken  on the 5th  or 6th day, the determi-
nation  is somewhat  more  difficult,  inasmuch as blood injected on the
5th day gave negative  results in 8.4 per cent, and that drawn  on the
6th day was negative in  14.3 per cent  of the cases.  It is possible  to
estimate the  spirochetocidal  action of  the  serum  from the  difference
in  the percentages  of infectability  of  the injected  blood  (Table III).INADA,  IDO,  HOKI,  ITO,  AND  WANI 491
TABLE  II.
Infection Experiments with Blood Drawn from Patients with Weil's Disease before
and after the Injection of Serum into the Patient.
Day of  Results.  Time  Positive  results.
illness on  Quantity  between  Day  of
No.  which  se-  Quanti  serum  in-  disease
rum treat-  Before  After  section  and  serum  With  Without
ment was  serum in-  serum in-  injected.  drawing  treatment.  serum  serum
given.  jection.  jection.  of blood.  treatment.  treatment.
cc.  hrs.  per cent  per cent
1  2  +  +  10  30  3
2  2  +  - 40  6  3  25.0  100.0
3  2  +  - 60  24  4
4  2  +  - 40  24  4
5  2  +  - 60  24  5
6  3  +  +  20  24  5
7  3  +  60  24  5
8  3  +  - 60  24  5
9  4  +  +  20  5  5  50.0  100.0
10  4  +  +  10  7  5
11  4  +  - 80  12  5
12  5  +  - 20  5  5
13  3  +  40  4th day.  6
14  4  +  - 35  22  6
15  5  +  - 40  13  6
16  5  +  +  10  7  6
17  5  +  +  10  24  6  71.4  77.7
18  5  - - 60  17  6
19  5  +  +'  60  12  6
20  6  +  +  10  3  6
21  6  - - 10  7  6
22  6  +  - 10  12  7
23  6  +  40  15  7  33.3  100.0
24  6  +  - 80  7  7
25  7  60
26  8  60  0  0
27  8  - _  10  7  8
Table III shows that in four cases in which human blood  not sub-
jected  to  serum  treatment  was  capable  of  infecting  guinea  pigs,
when  drawn  on  the  4th  day  of  the  disease  after  serum  treatment
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ratio  of  infection  of  the  guinea  pigs  with blood  drawn  after  the  ad-
ministration  of  serum is,  therefore,  25  per cent.  If we  compare this
figure with the percentages  of infection  (100 per cent)  found in guinea
pigs  receiving  blood  taken  before  serum  treatment,  a vast difference
is apparent.  This difference  in results  justifies  us fully in concluding
that  the blood  taken  from patients  after  they  have  received  serum
treatment  is  no longer  capable of infecting  guinea  pigs.  This means
either that the serum has destroyed  the spirochetes in the circulating
blood,  or  that the  spirochetes  have  lost  their virulence  and  are  no
longer  capable  of  producing  an  infection.  The  positive  result  in  a
single  case is to be  attributed  to the insufficient dosage of  the serum,
only  10 cc. having been injected in the case  in question.  On the 5th
day  the  percentage  of  guinea  pigs  infected  after  serum  treatment
was  50  per  cent;  without  serum  treatment,  100  per  cent.  The
positive  result  in 3 cases  is  also due  to  the  insufficient  quantity  of
serum administered,  as only from  10 to 20 cc. had been injected.  In
one  case the infection  experiment  proved negative  even when  20  cc.
of the serum had been administered.
On  the 6th day the percentage  of illness  of  the guinea pigs,  subse-
quent to serum  treatment,  was  71.4; without serum treatment,  77.7.
Among  the patients  there was one who  received  60  cc. of the serum,
and  whose  blood  was  still  capable  of  infecting  guinea  pigs  after  a
period  of  20 hours.  It is difficult  to  say why  the spirochetes  in the
blood were not destroyed  by the serum.
On the 7th day of illness,  33.3 per cent of guinea pigs infected with
blood taken after serum treatment became ill, and 100 per cent without
serum treatment.  Here we have the blood of a patient which caused
an  infection  in  one  guinea pig,  while  another  animal  remained  well.
This case has been included  among the positive results.
From  these  results  we may  conclude  that the  horse  serum  which
we  have  prepared,  administered  in suitable  doses,  is  capable  of  de-
stroying  completely  the  spirochetes  contained  in  the  circulating
blood, by the injection of 40 to 60  cc.  of serum in from 5 to  6 and up
to 24 hours.  A quantity  of  10 to 20  cc. of  the serum did not suffice
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The Influence  of the Serum Treatment upon  the Appearance of Anti-
bodies in the Blood.
As  we  have  stated  elsewhere,3 the  antibodies  in  Weil's  disease
are  not demonstrable  by  Pfeiffer's  method  in  the  blood  serum  of
patients inside  of  1 week  from  the  onset of  illness.  Beginning  with
the  8th  or  the  11th  day,  antibodies  make  their  appearance  in  the
blood, although  they  are at  first weak;  by the 12th  or the 13th day
they  are  fully  active.  They  are  rarely  active  as early  as  the  8th
day.  The time of  development  of the antibodies  in the blood seems
to be an individual  characteristic,  and differs  according to the sever-
ity of  the disease.  We have designated  as incomplete,  with respect
to  antibody  formation,  those  cases  in  which  the  infected  animals
(tested by Pfeiffer's  method)  outlived the  control  animals  by 4 days
or longer.  A difference  of 3  days in the life of the experimental  and
the control animals  should be regarded  as an indication of incomplete
immunity, but we have  taken  4 days  as a  conservative  limit.
TABLE  IV.
The Period  of Development of A ntibodies in the Blood of Patients  with Weil's Disease.
No  serum treatment.  Serum treatment.
Day of
illness.  Complete  Incomplete  Complete  Incomplete
develop-  develop-  Negative.  Total.  develop-  develop-  Negative.  Total.
ment.  ment.  ment.  ment.
6  3  3  1  1  7  9
7  5  5  2  3  5
8  2  2  6  10  3  8  7  18
9  3  4  7  3  1  2  6
10  1  2  3  5  5  2  12
11  1  2  3  1  1  2
12  3  1  4  3  3
13  43  43  7  7
One patient treated  with the serum showed  complete development
of antibodies in the blood on the 6th day of illness.  This phenomenon
never  occurs  with  the  blood  of  patients  who  have not  received  the
serum.  As shown in Table  IV, in  a large percentage  of the patients
Ido,  Y.,  Hoki,  R.,  Ito,  H,  Wani,  H.,  The  Prophylaxis  of  Weil's  Disease
(Spirochaetosis  Icterohaemorrhagica),  J. Exp.  Med.,  1916,  xxiv,  471.
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receiving  serum treatment complete development  of antibodies  could
be demonstrated  as  early as the 9th or 10th day, while this condition
appeared  only  on  the  11th  or  12th  day  when  no  serum  had  been
administered.  If  we  also  include  the  cases  of  incomplete  develop-
ment  of  antibodies,  we  are  justified in  concluding  that when  serum
treatment  is  given,  the  antibodies  make  their  appearance  in  the
blood  earlier  than  in  those  cases  where  no  serum  is  administered.
As far as the dosage  of serum in relation  to the development  of  anti-
bodies  is  concerned,  this  is difficult  to  estimate,  for the  intensity  of
the  disease  and  the  individual  circumstances  must  always  be  taken
into  account,  but  speaking  generally  it  may  be  said  that  develop-
ment  proceeds  more  rapidly  with  a  large  dose  of  serum.
The Influence of Serum Treatment upon the Spirochetes in the Body.
As Kaneko  and Okuda4 have discussed  this point in detail, we shall
present only a brief outline here.  It  may be said, in general, that the
number of spirochetes found at autopsy in the bodies  of patients  who
had received serum treatment  is much less than that found in patients
ill for an equal period of  time who received  no serum;  and, moreover,
the spirochetes in the first instance show a high degree of degeneration.
This  statement  is  particularly  true  of  the  kidneys  and  the  cardiac
muscles.
The Influence of Serum Treatment upon the Symptoms and the Course of
the Disease.
Whether or not the serum has an appreciable  effect upon the fever,
icterus,  and  hemorrhagic  diatheses can  be determined  only by  more
extensive  experience.  Up  to  the  present  time,  we  have  observed
no significant effect, except that with serum treatment the hemorrhages
are less  frequent  than without  serum treatment.  The "after fever,"
on the  other hand,  seems  to  occur more frequently  when  serum  has
been given.  Serum  therapy has no definite  effect upon the excretion
of  spirochetes  in  the  urine,  although  the period  of  excretion  of the
Kaneko  and  Okuda,  The  Pathological  and  Anatomical  State  of the  Lymph
Glands  in  the  Early  Stage,  and  the  Distribution  of  the  Spirochaeta  in  Them,
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living  spirochetes  seems  to  be  shorter  where  large  doses  of  serum
have been employed.
Secondary Manifestations.
We have  observed  few  secondary effects.  Following the  injection
of serum, no fever occurred.  In one  case  only was there a complaint
of headache, in another of tinnitus, and in still another there appeared
an  exanthem  at the  site  of injection.  These symptoms  which  were
all mild in character  disappeared completely  after  1 or 2 days.  Fre-
quently  complaint  was  made  of slight pains  at  the site  of  injection,
but these  also  disappeared  on  the following  day.
Spirochetocidal and Spirochetolytic Action of Serum.
We have recently observed a case in which we were able to demon-
strate  experimentally  upon  guinea  pigs  in a  conclusive  manner  the
spirochetocidal  and  spirochetolytic  action  of  serum  from  Weil's
disease.  The patient was  a  man of  65,  who was  taken  ill  suddenly
on May 1.  He was admitted  to the clinic on the 4th day of  the dis-
ease.  A  large  number  of  Spirocheta icterohcemorrhagic were  found
in the  blood  under  dark-field  illumination;  i.e.,  14  to  16  on  a  cover
slip  (60  to  70  optical  fields).  In no  other  case  have we  found  the
spirochetes  so numerous,  for  as a rule the  organisms  are  not readily
found in fresh blood preparations.  The number of spirochetes  found
before and after  serum  injection  was as  follows:
May 4,  2.00 p.m.  Admitted  to  clinic,  4th day  of illness.  Spirochetes  in the
blood,  14 to  16 per field,  as described  above.
3.00 p.m.  17 cc. of serum, very active  (from Feb.  26), subcutaneously.
6.00 p.m.  Spirochetes  14 to 16.
7.00 p.m.  Spirochetes  10 to  16.
8.00 p.m.  20 cc.  of serum, intravenously.
10.00 p.m.  No spirochetes  in 2 preparations.
12.00 m.  No spirochetes  in 3 preparations.
1.30 a.m.  No spirochetes  in 1 preparation.
At  1.00  a.m.  we  injected  2 cc.  of the  blood of  the patient  into  the peritoneal
cavity of a  guinea pig.  Up  to the  time of writing, May  14,  the animal  has re-
mained well.  At  8.30  a.m.,  3  cc.  of  the blood were  injected  into the peritoneal
cavity of another guinea  pig.  This  animal also  has not  become  ill.
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2  hours  after  intravenous  injection,  we  were  unable  to  find  any
spirochetes.  This  result  in  the  experimental  animal  is  in  entire
accord  with  the  spirochetocidal  and  spirochetolytic  action  of  the
serum  observed  in  human  beings.
SUMMARY.
Horses  immunized  with  cultures  of  Spirocheta icterohemorrhagice
yield  an immune  serum  having  therapeutic properties.
With rare exceptions the serum destroys completely the spirochetes
contained  in  the circulating blood.
The development  of antibodies is promoted by the serum injections.
The number  of  spirochetes  in  the  organs  is reduced by the treat-
ment.
Secondary manifestations  due to  the  serum  are  slight  and  disap-
pear promptly.
The ultimate  effects of  the serum treatment  on the symptoms and
final  outcome  of the disease have still  to be  determined.